Cardiovascular risk factors and the prediabetic syndrome

Annals of Medicine

Volumn 28, Issue 4, 1996, Pages 363-370

  Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Coronary heart disease; Diabetes; Insulin; Prediabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR DISEASE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029835934     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999094     Document Type: Article

References (25)

1. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-60.
2. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive during 9% year follow-up of the Helsinki Policeman Study population. Acta Med Scand Suppl 1985; 701: 38-52.
3. Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study 10 years later. Horm Metab Res Suppl 1985; 15: 41-6.
4. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol 1994; 4: 40-5.
5. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 1992; 35: 766-70.
6. Laakso M, Sarlund H, Salonen R, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991; 11: 1068-76.
7. Bressler P, Bailey S, Saad R, DeFronzo RA. Insulin resistance and coronary artery disease (CAD): the missing link. Diabetes 1992; 41 (Suppl 1): 24A.
8. Howard G, O'Leary D, Ayad M, Wagenknecht L, for the IRAS Investigators. Lower insulin sensitivity is related to atherosclerosis in non-diabetics. The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes 1994; 43 (Suppl 1): 60A.
9. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet 1989; i: 1356-9.
10. Sicree RA, Zimmet PZ, King HOM, Coventry JS. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 1987; 36: 179-86.
11. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 1990; 39: 283-8.
12. Hamman RF. Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992; 8: 287-338.
13. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 1990; 39: 104-11.
14. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E. Risk factors for NIDDM in white populations: Paris Prospective Study. Diabetes 1991; 40: 796-9.
15. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993; 36: 553-9.
16. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-15.
17. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. W Engl J Med 1993; 329: 1988-92.
18. Knowler WC, Bennett PH, Hamman RF, et al. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978; 108: 497-505.
19. Stern MP, Gaskill SP, Hazuda HP, Gardner LI, Haffner SM. Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia 1983; 24: 272-7.
20. Hamman RF, Marshall JA, Baxter J, et al. Methods and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 1989; 129: 295-311.
21. Aronoff SL, Bennett PH, Gorden P, Rushforth N, Miller M. Unexplained hyperinsulinemia in normal and 'prediabetic' Pima Indians compared with normal Caucasians: an example of racial differences in insulin secretion. Diabetes 1977; 26: 827-40.
22. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315: 220-24.
23. Haffner SM, Bowsher RR, Mykkänen L, et al. Proinsulin and specific insulin concentrations in high and low risk populations for non-insulin dependent diabetes mellitus. Diabetes 1994; 43: 1490-3.
24. Boyko EJ, Keane EM, Marshall JA, Hamman RF. Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. Diabetes 1991; 40: 509-15.
25. Nagulesparan M, Savage PJ, Knowler WG, et al. Increased in vivo insulin resistance in non-diabetic Pima Indians compared with Caucasians. Diabetes 1982; 31: 952-6.